{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:41:02Z","timestamp":1772696462114,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jep.2020.113706","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T04:46:53Z","timestamp":1608266813000},"page":"113706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters"],"prefix":"10.1016","volume":"269","author":[{"given":"Haoyu","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-2361","authenticated-orcid":false,"given":"Su","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jep.2020.113706_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep4.1013","article-title":"Update on pharmacotherapies for cholestatic liver disease","volume":"1","author":"Ali","year":"2017","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.jep.2020.113706_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0306-9877(86)90137-4","article-title":"Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids","volume":"19","author":"Attili","year":"1986","journal-title":"Med. Hypotheses"},{"issue":"1 Suppl. l","key":"10.1016\/j.jep.2020.113706_bib3","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.jep.2020.113706_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jplph.2005.04.013","article-title":"Induction of drug metabolizing enzymes by vitamin E","volume":"162","author":"Brigelius-Flohe","year":"2005","journal-title":"J. Plant Physiol."},{"issue":"3","key":"10.1016\/j.jep.2020.113706_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.10.3.409","article-title":"FXR: a target for cholestatic syndromes?","volume":"10","author":"Cai","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.jep.2020.113706_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.jep.2020.113706_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112588","article-title":"Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review","volume":"11","author":"Chambers","year":"2019","journal-title":"Nutrients"},{"issue":"23","key":"10.1016\/j.jep.2020.113706_bib8","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1111\/bph.14035","article-title":"p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice","volume":"174","author":"Chen","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2020.113706_bib9","first-page":"18","article-title":"Novel clinical application of da-huang-Xiao-Shi decoction","volume":"27","author":"Chen","year":"2011","journal-title":"Chin. Commun. Doctors"},{"issue":"1","key":"10.1016\/j.jep.2020.113706_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter","volume":"121","author":"Denson","year":"2001","journal-title":"ntcp. Gastroenterology"},{"issue":"1","key":"10.1016\/j.jep.2020.113706_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1089-3261(05)70363-9","article-title":"Liver disease in cystic fibrosis","volume":"2","author":"Flora","year":"1998","journal-title":"Clin. Liver Dis."},{"issue":"2","key":"10.1016\/j.jep.2020.113706_bib13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jep.2020.113706_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00008571-200410000-00001","article-title":"Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene","volume":"14","author":"Gnerre","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"51","key":"10.1016\/j.jep.2020.113706_bib15","doi-asserted-by":"crossref","first-page":"83951","DOI":"10.18632\/oncotarget.13796","article-title":"Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jep.2020.113706_bib16","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.2741\/3526","article-title":"Liver diseases related to MDR3 (ABCB4) gene deficiency","volume":"14","author":"Gonzales","year":"2009","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.jep.2020.113706_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00534-011-0396-3","article-title":"Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids","volume":"18","author":"Gonzalez","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"10.1016\/j.jep.2020.113706_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007226","article-title":"Sinusoidal (basolateral) bile salt uptake systems of hepatocytes","volume":"16","author":"Hagenbuch","year":"1996","journal-title":"Semin. Liver Dis."},{"issue":"12","key":"10.1016\/j.jep.2020.113706_bib19","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1248\/bpb.32.2046","article-title":"Altered expression of nuclear receptors affects the expression of metabolic enzymes and transporters in a rat model of cholestasis","volume":"32","author":"Hasegawa","year":"2009","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.jep.2020.113706_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/aps.2014.117","article-title":"FXR and liver carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"1\u20132","key":"10.1016\/j.jep.2020.113706_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-013-1933-y","article-title":"Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-\/-) mice","volume":"389","author":"Hrycay","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jep.2020.113706_bib22","doi-asserted-by":"crossref","first-page":"104234","DOI":"10.1016\/j.phrs.2019.04.018","article-title":"Drugs and hepatic transporters: a review","volume":"154","author":"Jetter","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2020.113706_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpba.2019.05.050","article-title":"Simultaneous determination of multiple compounds of Da-Huang-Xiao-Shi decoction in rat plasma by LC-MS\/MS and its application in a pharmacokinetic study","volume":"174","author":"Jin","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.jep.2020.113706_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.dld.2018.12.026","article-title":"FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury","volume":"51","author":"Kong","year":"2019","journal-title":"Dig. Liver Dis."},{"issue":"10","key":"10.1016\/j.jep.2020.113706_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jep.2020.113706_bib26","doi-asserted-by":"crossref","first-page":"153153","DOI":"10.1016\/j.phymed.2019.153153","article-title":"Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor","volume":"68","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2020.113706_bib27","doi-asserted-by":"crossref","first-page":"152948","DOI":"10.1016\/j.phymed.2019.152948","article-title":"Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice","volume":"62","author":"Li","year":"2019","journal-title":"Phytomedicine"},{"issue":"4 Pt B","key":"10.1016\/j.jep.2020.113706_bib28","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"28","key":"10.1016\/j.jep.2020.113706_bib29","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.3748\/wjg.v20.i28.9418","article-title":"Atypical causes of cholestasis","volume":"20","author":"Nguyen","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.jep.2020.113706_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/jgh.13738","article-title":"Diagnostic considerations for cholestatic liver disease","volume":"32","author":"Pollock","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jep.2020.113706_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1568008054863781","article-title":"Role of FXR in regulating bile acid homeostasis and relevance for human diseases","volume":"5","author":"Rizzo","year":"2005","journal-title":"Curr. Drug Targets - Immune, Endocr. Metab. Disord."},{"key":"10.1016\/j.jep.2020.113706_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jep.2018.09.041","article-title":"Reversing effects of ginsenosides on LPS-induced hepatic CYP3A11\/3A4 dysfunction through the pregnane X receptor","volume":"229","author":"Sun","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.jep.2020.113706_bib34","first-page":"537","article-title":"Evaluation of adults with acute viral hepatitis a and review of the literature","volume":"164","author":"Tekin","year":"2013","journal-title":"Clin. Ter."},{"issue":"4","key":"10.1016\/j.jep.2020.113706_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/bega.2001.0207","article-title":"Animal models for primary sclerosing cholangitis","volume":"15","author":"Vierling","year":"2001","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jep.2020.113706_bib36","first-page":"7475626","article-title":"Peroxisome proliferator-activated receptor-gamma prevents cholesterol gallstone formation in C57bl mice by regulating bile acid synthesis and enterohepatic circulation","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jep.2020.113706_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112672","article-title":"Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses","volume":"254","author":"Wang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.jep.2020.113706_bib38","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jep.2020.113706_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1940-6207.CAPR-11-0320","article-title":"Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis","volume":"5","author":"Wertheim","year":"2012","journal-title":"Canc. Prev. Res."},{"issue":"36","key":"10.1016\/j.jep.2020.113706_bib40","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","article-title":"Novel insight into mechanisms of cholestatic liver injury","volume":"18","author":"Woolbright","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jep.2020.113706_bib41","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3389\/fphar.2019.01685","article-title":"Baicalin protects against 17alpha-ethinylestradiol-induced cholestasis via the sirtuin 1\/hepatic nuclear receptor-1alpha\/farnesoid X receptor pathway","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.jep.2020.113706_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-8278(00)80160-9","article-title":"Obstructive jaundice impairs hepatic sinusoidal endothelial cell function and renders liver susceptible to hepatic ischemia\/reperfusion","volume":"33","author":"Yoshidome","year":"2000","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jep.2020.113706_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","article-title":"Effect of bile duct ligation on bile acid composition in mouse serum and liver","volume":"32","author":"Zhang","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.jep.2020.113706_bib44","series-title":"Jin Gui Yao Lue. Peking","author":"Zhang","year":"2005"},{"key":"10.1016\/j.jep.2020.113706_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-017-0462-7","article-title":"Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice","volume":"15","author":"Zheng","year":"2017","journal-title":"BMC Biol."},{"key":"10.1016\/j.jep.2020.113706_bib46","doi-asserted-by":"crossref","first-page":"111860","DOI":"10.1016\/j.jep.2019.111860","article-title":"UPLC-MS-based metabonomic analysis of intervention effects of Da-Huang-Xiao-Shi decoction on ANIT-induced cholestasis","volume":"238","author":"Zhu","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.jep.2020.113706_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","article-title":"Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations","volume":"3","author":"Zollner","year":"2006","journal-title":"Mol. Pharm."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874120335947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874120335947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:48:44Z","timestamp":1759942124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874120335947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"alternative-id":["S0378874120335947"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2020.113706","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2020.113706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113706"}}